Glaukos Corp. (GKOS)
177.47
-2.88
(-1.60%)
USD |
NYSE |
Sep 04, 16:00
177.48
+0.01
(+0.01%)
Pre-Market: 20:00
Glaukos SG&A Expense (TTM) : 386.70M for June 30, 2026
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical SG&A Expense (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 386.70M |
| March 31, 2026 | 354.02M |
| December 31, 2025 | 331.75M |
| September 30, 2025 | 306.05M |
| June 30, 2025 | 287.05M |
| March 31, 2025 | 269.86M |
| December 31, 2024 | 261.17M |
| September 30, 2024 | 255.20M |
| June 30, 2024 | 245.44M |
| March 31, 2024 | 232.39M |
| December 31, 2023 | 224.07M |
| September 30, 2023 | 212.96M |
| June 30, 2023 | 205.86M |
| March 31, 2023 | 202.63M |
| December 31, 2022 | 192.92M |
| September 30, 2022 | 188.56M |
| June 30, 2022 | 185.88M |
| March 31, 2022 | 181.28M |
| December 31, 2021 | 179.26M |
| September 30, 2021 | 175.48M |
| June 30, 2021 | 169.96M |
| March 31, 2021 | 162.78M |
| December 31, 2020 | 171.40M |
| September 30, 2020 | 187.22M |
| Date | Value |
|---|---|
| June 30, 2020 | 192.72M |
| March 31, 2020 | 192.26M |
| December 31, 2019 | 176.64M |
| September 30, 2019 | 149.13M |
| June 30, 2019 | 136.32M |
| March 31, 2019 | 127.30M |
| December 31, 2018 | 119.53M |
| September 30, 2018 | 113.39M |
| June 30, 2018 | 105.90M |
| March 31, 2018 | 101.93M |
| December 31, 2017 | 96.26M |
| September 30, 2017 | 90.79M |
| June 30, 2017 | 83.50M |
| March 31, 2017 | 73.95M |
| December 31, 2016 | 64.76M |
| September 30, 2016 | 56.65M |
| June 30, 2016 | 51.04M |
| March 31, 2016 | 48.43M |
| December 31, 2015 | 43.96M |
| September 30, 2015 | 37.52M |
| June 30, 2015 | 26.28M |
| March 31, 2015 | 13.76M |
| March 31, 2014 | 5.948M |
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Abbott Laboratories | 13.94B |
| Alphatec Holdings, Inc. | 524.06M |
| Artivion, Inc. | 254.77M |
| ICU Medical, Inc. | 615.07M |
| Insulet Corp. | 1.309B |